Sei Investments Co. cut its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 24.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 245,729 shares of the company’s stock after selling 77,808 shares during the quarter. Sei Investments Co.’s holdings in Astera Labs were worth $26,934,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Lido Advisors LLC boosted its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Perigon Wealth Management LLC raised its holdings in Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after purchasing an additional 73 shares in the last quarter. Sound Income Strategies LLC raised its holdings in Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares in the last quarter. Venturi Wealth Management LLC lifted its position in shares of Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after buying an additional 84 shares during the last quarter. Finally, Goldstein Advisors LLC lifted its position in shares of Astera Labs by 5.8% during the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after buying an additional 88 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
ALAB has been the subject of several recent analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Barclays upped their price target on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Needham & Company LLC upped their target price on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $282.00.
Insider Activity
In related news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the transaction, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,676,845 shares of company stock valued at $444,928,806 in the last quarter. 10.40% of the stock is currently owned by company insiders.
Astera Labs Stock Performance
Astera Labs stock opened at $260.23 on Wednesday. The business’s 50-day simple moving average is $360.60 and its two-hundred day simple moving average is $227.59. The company has a market cap of $44.61 billion, a PE ratio of 175.83, a PEG ratio of 3.27 and a beta of 3.66. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the firm earned $0.33 earnings per share. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
